Brilique 90 mg

Brilique 90 mg is a medicine authorised by Swissmedic under authorisation number 66822. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 March 2018 and the authorisation is valid without a time limit. ATC code B01AC24 places the medicine in the group Antithrombotic agents.

Dispensing category B
Authorisation number 66822
ATC B01AC24
Synthetic medicines

Authorisation data
Authorisation number	66822
Name	Brilique 90 mg
Full name	Brilique 90 mg, Schmelztabletten
Authorisation holder	AstraZeneca AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	B01AC24
First authorisation	08 March 2018
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Brilique 90 mg, Schmelztabletten	B	08 March 2018

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	10	Tablette(n)	B01AC24	06.03.2.	B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

AxultaAuthorisation number 65402 · ATC A06AX04B Bricanyl TurbuhalerAuthorisation number 48943 · ATC R03AC03B Brilique 90 mgAuthorisation number 61389 · ATC B01AC24B Calquence 100 mgAuthorisation number 68817 · ATC L01EL02A Daxas 500 ugAuthorisation number 60484 · ATC R03DX07B Fasenra 30 mg /1 mlAuthorisation number 66582 · ATC R03DX10B Fasenra Pen 30 mg /1 mlAuthorisation number 67581 · ATC R03DX10B FaslodexAuthorisation number 56778 · ATC L02BA03B

Frequently asked questions

Is Brilique 90 mg authorised in Switzerland?

Yes. Brilique 90 mg is authorised by Swissmedic under authorisation number 66822, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Brilique 90 mg have?

Brilique 90 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Brilique 90 mg?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.